| Biological Information | |
|---|---|
| Background Information: | 2-(Methylthio)adenosine 5′-diphosphate (2-methylthio-ADP) induces platelet aggregation and inhibits cAMP accumulation in platelets in-vitro. It's 3-5 times more active than ADP as an aggregating agent, and 150-200 times more active as a cAMP accumulation inhibitor. Potent agonist of the P2Y1, P2Y12, and P2Y13 purinoceptors. |
| Target Name: | 2-methylthio-ADP |
| Usage | |
| Product Type: | Control Ligands & Inhibitors |
| Application: | Drug Discovery & Development |
| Storage Conditions: | Store at ≤-20°C. Please avoid multiple freeze/thaw cycles. |
| Usage Disclaimer: | These products may be covered by issued US and/or foreign patents, patent application and subject to Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information. |
| Additional Information | |
| Brand: | DiscoverX |
2-(methylthio)-ADP
2-(Methylthio)adenosine 5′-diphosphate (2-methylthio-ADP) induces platelet aggregation and inhibits cAMP accumulation in platelets in-vitro. This product is provided as 5 mg of dry powder alongside reconstitution buffer..
Datasheets
92-1177 Datasheet
View Document